delafloxacin vs zinc sulfate
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of delafloxacin and zinc sulfate. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Oral administration of BAXDELA with antacids containing aluminum or magnesium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as didanosine buffered tablets for oral suspension or the pediatric powder for oral solution, may substantially interfere with the absorption of BAXDELA, resulting in systemic concentrations considerably lower than desired.
Baxdela
Zinc, Orazinc
Baxdela is an antibiotic that fights bacteria in your body. It is used to treat certain skin infections and pneumonia.
Zinc sulfate is a mineral supplement. It can help with minor eye irritation.
Baxdela treats acute bacterial skin infections and skin structure infections in adults. It can treat infections caused by bacteria like Staphylococcus aureus (including MRSA), Streptococcus, and others. Baxdela also treats community-acquired bacterial pneumonia in adults, caused by bacteria like Streptococcus pneumoniae, Klebsiella pneumoniae, and others.
This medicine can help with eye discomfort and redness. It is for minor eye irritations. It provides temporary relief.
Baxdela belongs to a class of drugs called fluoroquinolones. It works by stopping bacteria from multiplying. This helps your body fight off the infection.
Zinc sulfate works as a mild astringent. This means it can help to relieve minor eye irritation.
- • Nausea
- • Diarrhea
- • Headache
- • Changes in liver enzyme tests
- • Vomiting
No common side effects listed.
No adverse event reports.
- Diarrhoea 215
- Fatigue 172
- Nausea 166
- Death 153
- Pain 146
Baxdela has a boxed warning. It can cause serious side effects like tendon problems, nerve damage, and central nervous system problems. It can also make muscle weakness worse if you have myasthenia gravis. Stop taking Baxdela right away if you have any of these side effects.
No specific warnings noted.
It is not known if Baxdela will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Baxdela passes into breast milk. Talk to your doctor about the best way to feed your baby if you take Baxdela.
It is not known if zinc sulfate can harm an unborn baby. Talk to your doctor if you are pregnant or breastfeeding.
Also Compare, Nearby Drugs
Compare delafloxacin with
Compare zinc sulfate with
How to Read This delafloxacin vs zinc sulfate Comparison
delafloxacin is classified in the Fluoroquinolone Antibiotic drug class, while zinc sulfate sits within the Mineral Supplement class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, delafloxacin has 0 submissions while zinc sulfate has 852. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to zinc binds to the antibiotic in your stomach, which stops the body from absorbing it properly. this can make the antibiotic much less effective at fighting your infection.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for delafloxacin or zinc sulfate.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.